Why Precipio, Inc.’s (PRPO) Stock Is Down 5.37%
As of Friday, August 21, Precipio, Inc.’s PRPO share price has dipped by 5.37%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Commentary & Analysis
Why Precipio, Inc.’s (PRPO) Stock Is Down 10.84%
As of Friday, May 15, Precipio, Inc.’s PRPO share price has dipped by 10.84%, which has investors questioning if this is right time to buy.Rosalio Madrigal
Why Precipio, Inc.’s (PRPO) Stock Is Down 13.32%
As of Friday, May 15, Precipio, Inc.’s PRPO share price has dipped by 13.32%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Precipio, Inc.’s (PRPO) Stock Is Down 6.66%
As of Monday, May 11, Precipio, Inc.’s PRPO share price has dipped by 6.66%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Precipio, Inc.’s (PRPO) Stock Is Down 5.15%
As of Tuesday, April 21, Precipio, Inc.’s PRPO share price has dipped by 5.15%, which has investors questioning if this is right time to buy.Michael Rose
Financial Summary
| Share Statistics | PRPO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $47.0 | $1,727.1 | 15% |
|
| Shares Out (Mil) | 1.8 | 77.7 | 7% |
|
| Institutional Ownership | 41.3% | 87.7% | 17% |
|
| Float (Mil) | 1.4 | 55.7 | 4% |
|
| Beta | 1.29 | 0.81 | 75% |
|
| Avg Daily Volume (000s) | 149 | 652 | 39% |
|
| Price Change (52-week) |
57.4% | 78.7% | 85% |
|
| Growth | PRPO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 31.5% | 10.6% | 90% |
|
| Net Income (5yr) | 48.1% | (0.3%) | 93% |
|
| EPS (5yr) | 57.8% | 3.0% | 95 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (18.4%) | (17.7%) | 37% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | PRPO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $27 | $1,505 | 15% |
|
| Net Income (TTM) (Mil) | ($1) | $26 | 37% |
|
| EPS (TTM) | ($0.697) | $0.200 | 25% |
|
| Operating Cash Flow (TTM) (Mil) | $1 | $157 | 33% |
|
| Net Cash Flow (TTM) (Mil) | $2 | $7 | 48% |
|
| Long-Term Debt (Q1) (Mil) | $3 | $374 | 22% |
|
| Enterprise Value (Q1) (Mil) | $55 | $2,284 | 17% |
|
| Valuation | PRPO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.18 | 3.08 | 67% |
|
| P/E | na | 24.9 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | PRPO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 44.1% | 27.6% | 55% |
|
| Net Margin | (4.5%) | 1.2% | 26% |
|
| ROA | (6.1%) | 2.1% | 28% |
|
| ROE | (9.0%) | 6.8% | 28% |
|
| Liabilities to Assets | 30.8% | 61.3% | 22% |
|
| F-Score | 5 | 5 | 50% |
|
Precipio, Inc. did not pass any screens on 9/22/2026.
